title: Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast-phase myeloproliferative neoplasms.
authors.affiliation: Haematology Department, Institut Paoli Calmettes, Marseille, France.|Aix-Marseille University, Marseille, France.
authors.forename: Raynier
authors.initials: R
authors.lastname: Devillier
authors.affiliation: Adult Haematology Department, Saint Louis Hospital, Paris, France.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Raffoux
authors.affiliation: Haematology Department, Institut Paoli Calmettes, Marseille, France.
authors.forename: Jérôme
authors.initials: J
authors.lastname: Rey
authors.affiliation: Adult Haematology Department, Saint Louis Hospital, Paris, France.
authors.forename: Etienne
authors.initials: E
authors.lastname: Lengline
authors.affiliation: Adult Haematology Department, Saint Louis Hospital, Paris, France.
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Ronchetti
authors.affiliation: Senior Haematology Department, Saint Louis Hospital, Paris, France.
authors.forename: Marie
authors.initials: M
authors.lastname: Sebert
authors.affiliation: Adolescents and Young Adults Haematology Department, Saint Louis Hospital, Paris, France.|EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Boissel
authors.affiliation: Allo Stem Cell Transplantation Department, Saint Louis Hospital, Paris, France.
authors.forename: Marie
authors.initials: M
authors.lastname: Robin
authors.affiliation: Haematology Department, Institut Paoli Calmettes, Marseille, France.|Aix-Marseille University, Marseille, France.
authors.forename: Norbert
authors.initials: N
authors.lastname: Vey
authors.affiliation: Adult Haematology Department, Saint Louis Hospital, Paris, France.|EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France.|Centre d'Investigation Clinique (CIC), Saint Louis Hospital, Paris, France.
authors.forename: Jean-Jacques
authors.initials: JJ
authors.lastname: Kiladjian
authors.affiliation: Adult Haematology Department, Saint Louis Hospital, Paris, France.|EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France.
authors.forename: Herve
authors.initials: H
authors.lastname: Dombret
authors.affiliation: Adult Haematology Department, Saint Louis Hospital, Paris, France. cluzeau.thomas@gmail.com.|EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France. cluzeau.thomas@gmail.com.|INSERM U1065, Centre mediterraneen de Medecine Moleculaire, Nice, France. cluzeau.thomas@gmail.com.
authors.forename: Thomas
authors.initials: T
authors.lastname: Cluzeau
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D054438:Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009570:Nitriles; D011720:Pyrazoles / Q000008:administration & dosage; D011743:Pyrimidines; D016896:Treatment Outcome
chemical_list: D009570:Nitriles; D011720:Pyrazoles; D011743:Pyrimidines; D003561:Cytarabine; C540383:ruxolitinib; D015255:Idarubicin; D003630:Daunorubicin
keywords: acute myeloid leukaemia; blast phase; intensive chemotherapy; myeloproliferative neoplasm; ruxolitinib